Centrifuge adds Symbiotic liquidity network across $1.6B in Janus Henderson, NYLIM funds
Centrifuge integrated Symbiotic’s liquidity network, Liquid Lane, across three tokenized funds totaling about $1.6 billion in assets: Janus Henderson’s JAAA and JTRSY, and New York Life Investment Management’s HYB. The setup gives eligible holders a path to convert fund positions into USDC through an onchain RFQ marketplace. Market makers can source liquidity from vaults to meet redemption requests, then redeem the acquired fund tokens with the issuer or resell them via another RFQ trade. The arrangement provides immediate USDC to investors while standard fund redemptions settle separately. Centrifuge already has other liquidity routes, including Wintermute for JTRSY and a separate near-instant redemption setup for HYB. Symbiotic says its main difference is a capital structure that lets multiple market makers participate without pre-funding inventory for each asset. It argues broader aggregation of redemption demand could improve liquidity economics as tokenized funds gain use as collateral and financing assets.
